N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide
C27H24F5N3O4 — CID 158279988
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide
N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide (PubChem CID 158279988) has the molecular formula C27H24F5N3O4 and a molecular weight of 549.50 g/mol. Its IUPAC name is N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide.
Molecular Properties
| Compound Name | N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide |
|---|---|
| PubChem CID | 158279988 |
| Molecular Formula | C27H24F5N3O4 |
| Molecular Weight | 549.50 g/mol |
| Exact Mass | 549.17 |
| IUPAC Name | N-[5-[2-[6-(3,5-difluorophenyl)-3-pyridinyl]acetyl]-2-(trifluoromethoxy)phenyl]-2-morpholin-4-ylpropanamide |
| SMILES | CC(C(=O)Nc1cc(C(=O)Cc2ccc(-c3cc(F)cc(F)c3)nc2)ccc1OC(F)(F)F)N1CCOCC1 |
| InChI | InChI=1S/C27H24F5N3O4/c1-16(35-6-8-38-9-7-35)26(37)34-23-13-18(3-5-25(23)39-27(30,31)32)24(36)10-17-2-4-22(33-15-17)19-11-20(28)14-21(29)12-19/h2-5,11-16H,6-10H2,1H3,(H,34,37) |
| InChIKey | GKCBAIIYXRASOM-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 80.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 549.50 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158279988 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.